Cargando…

Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System

PURPOSE: We investigated the dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using the CyberKnife static tracking system. METHODS: Four-dimensional computed tomography scans of a dynamic thorax phantom were acquired. Two motion ranges, 3 collimator sizes, and 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yu, Liu, Hong-Yuan, Liang, Zhi-Wen, Nie, Xin, Yang, Jing, Liu, Gang, Li, Qin, Yang, Zhi-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600499/
https://www.ncbi.nlm.nih.gov/pubmed/31248330
http://dx.doi.org/10.1177/1533033819859448
_version_ 1783431130203029504
author Chang, Yu
Liu, Hong-Yuan
Liang, Zhi-Wen
Nie, Xin
Yang, Jing
Liu, Gang
Li, Qin
Yang, Zhi-Yong
author_facet Chang, Yu
Liu, Hong-Yuan
Liang, Zhi-Wen
Nie, Xin
Yang, Jing
Liu, Gang
Li, Qin
Yang, Zhi-Yong
author_sort Chang, Yu
collection PubMed
description PURPOSE: We investigated the dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using the CyberKnife static tracking system. METHODS: Four-dimensional computed tomography scans of a dynamic thorax phantom were acquired. Two motion ranges, 3 collimator sizes, and 4 treatment starting phases were investigated. Monte Carlo dose distributions were calculated on internal target volume with a treatment-specific setup margin for 6 Gy/1 fraction. Dosimetric effects of intrafractional tumor motion were assessed with Gafchromic films. γ (5%/3 mm), dose differences, and distance to agreement were analyzed. RESULTS: With 30 mm collimator plans, the measured dose passed the criteria γ (5%/3 mm) in all tumor motion ranges. The γ passing rates of the plans using 20 mm or 20+35 mm collimators were much lower than that with 30 mm collimator, especially with the 30 mm tumor motion range. The measured dose of 10 mm tumor motion ranges all passed the 90% criteria of γ (5%/3 mm), the results being much better than those of 30 mm tumor motion ranges, which were below 80%. The results of same delivered plan but treated with different starting phases varies greatly. CONCLUSION: Xsight Lung Tracking technique should be used with caution in lung cancer stereotactic body radiation therapy because the temporal dose variations can be significant.
format Online
Article
Text
id pubmed-6600499
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-66004992019-07-08 Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System Chang, Yu Liu, Hong-Yuan Liang, Zhi-Wen Nie, Xin Yang, Jing Liu, Gang Li, Qin Yang, Zhi-Yong Technol Cancer Res Treat Original Article PURPOSE: We investigated the dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using the CyberKnife static tracking system. METHODS: Four-dimensional computed tomography scans of a dynamic thorax phantom were acquired. Two motion ranges, 3 collimator sizes, and 4 treatment starting phases were investigated. Monte Carlo dose distributions were calculated on internal target volume with a treatment-specific setup margin for 6 Gy/1 fraction. Dosimetric effects of intrafractional tumor motion were assessed with Gafchromic films. γ (5%/3 mm), dose differences, and distance to agreement were analyzed. RESULTS: With 30 mm collimator plans, the measured dose passed the criteria γ (5%/3 mm) in all tumor motion ranges. The γ passing rates of the plans using 20 mm or 20+35 mm collimators were much lower than that with 30 mm collimator, especially with the 30 mm tumor motion range. The measured dose of 10 mm tumor motion ranges all passed the 90% criteria of γ (5%/3 mm), the results being much better than those of 30 mm tumor motion ranges, which were below 80%. The results of same delivered plan but treated with different starting phases varies greatly. CONCLUSION: Xsight Lung Tracking technique should be used with caution in lung cancer stereotactic body radiation therapy because the temporal dose variations can be significant. SAGE Publications 2019-06-27 /pmc/articles/PMC6600499/ /pubmed/31248330 http://dx.doi.org/10.1177/1533033819859448 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Chang, Yu
Liu, Hong-Yuan
Liang, Zhi-Wen
Nie, Xin
Yang, Jing
Liu, Gang
Li, Qin
Yang, Zhi-Yong
Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
title Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
title_full Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
title_fullStr Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
title_full_unstemmed Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
title_short Dosimetric Effect of Intrafraction Tumor Motion in Lung Stereotactic Body Radiotherapy Using CyberKnife Static Tracking System
title_sort dosimetric effect of intrafraction tumor motion in lung stereotactic body radiotherapy using cyberknife static tracking system
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600499/
https://www.ncbi.nlm.nih.gov/pubmed/31248330
http://dx.doi.org/10.1177/1533033819859448
work_keys_str_mv AT changyu dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT liuhongyuan dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT liangzhiwen dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT niexin dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT yangjing dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT liugang dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT liqin dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem
AT yangzhiyong dosimetriceffectofintrafractiontumormotioninlungstereotacticbodyradiotherapyusingcyberknifestatictrackingsystem